MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that the Company will participate in the Rodman & Renshaw 13th Annual Global Investment Conference taking place September 12-13, 2011 at the Waldorf Astoria Hotel in New York City.
